Overview

Companies

Metrics

Content

Purchase

Pharmaceutical CME departments struggle to measure performance for a number of reasons. The lack of hard measures for medical education, along with a fear of appearing non-compliant stops many companies from tracking return on investment (ROI). Many medical education departments use post-CME outcomes measures to judge the effectiveness of their investments in CME events. Unfortunately, attendance figures are the only hard measurement available from outcomes measurements – and high attendance numbers do not always translate into effective programs.

Cutting Edge Information’s study presents best practices and strategies for measuring CME program effectiveness, as well as explores the recent changes that pharmaceutical CME teams have undergone since the Office of Inspector General (OIG) published its guidance document in 2003. The study is a comprehensive look at the pharmaceutical industry’s strategies and support for CME in the current compliance environment.

Pharmaceutical CME: Measuring Program Effectiveness in the Compliance Environment explores the current challenges facing continuing medical education, as well as includes trend analysis, successful strategies and best practices. The study’s major focus areas include:

• CME Structure, Staffing and Spending – Cutting Edge Information collected case studies and benchmark data to underscore CME investment trends and reorganization strategies to remain compliant with industry regulations.
   
• CME Program Strategies and Goals – Analysts compared industry-leading strategies and outlined goals for CME departments.
   
• Grants Process – Our study identifies best practices in standardizing the CME grants request process. The study also outlines changes in the process to meet with new compliance standards.
   
• Evaluating Program Management and Effectiveness – The most effective CME departments in the pharmaceutical industry invest in various vehicles to deliver medical education to target physician audiences. Cutting Edge Information compiled best practices and industry trends regarding the ideal CME media mix, including live events, eCME and enduring content.
   
• Performance Measurement – Our analysts took a strategic look at hard and soft measures that pharma companies use to determine return on investment and return on education.
   
• CME Compliance – The study outlines top compliance challenges and presents solutions for pharmaceutical companies to operate effective CME programs in an ever-changing compliance environment.

 

More Cutting Edge Information Reports: